ScreenerHero
DIMSartorius Stedim Biotech S.A.
EPA · FR · Healthcare · Medical Instruments & Supplies · sartorius.com
192.50EUR-1.33%Mkt Cap: 20.46B $P/E: 64.50

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; b…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Société anonyme
$81.53BUSDP/E 30.5
BOX
Becton, Dickinson and Company
$49.98BUSDP/E 34.1
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
ALC
Alcon AG
$32.71BUSDP/E 55.9
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
SRT3
Sartorius Aktiengesellschaft
$18.52BUSDP/E 86.9
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$14.73BUSDP/E 69.1
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1

Key Statistics

Company
Market Cap20.46B $
Enterprise Value22.93B $
Revenue (TTM)3.27B $
Gross Profit1.46B $
Net Income (TTM)288.70M $
Revenue/Share33.60 USD
Last Price192.50 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees10.5K
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINFR0013154002
Valuation
P/E (Trailing)64.50
P/E (Forward)32.76
PEG1.64
EV/EBITDA25.84
EV/Revenue7.02
P/S6.31
P/B4.46
EPS (TTM)3.02
EPS (Forward)5.95
52W Range
150.0057% of range224.00
52W High224.00 EUR
52W Low150.00 EUR
Profitability
Gross Margin45.33%
Oper. Margin20.11%
EBITDA Margin27.17%
Profit Margin8.95%
ROE6.49%
ROA3.33%
Growth
Revenue Growth2.80%
Earnings Growth37.10%
Cash Flow & Leverage
Operating CF752.39M $
CapEx (TTM)427.39M $
FCF Margin6.74%
FCF Yield1.08%
Net Debt2.39B $
Net Debt/EBITDA2.69
Balance Sheet
Debt/Equity0.64
Current Ratio1.16
Quick Ratio0.48
Book Value/Sh43.74 EUR
Cash/Share2.108 EUR
Dividends
Fwd Div Rate0.6900 EUR
Trail. Div Rate0.6900 EUR
Div. Yield0.38%
5Y Avg Yield0.40%
Payout Ratio22.92%
Ex-Div DateMar 31, 2026
Pay Date—
Splits
Last Split6:1
Split DateMay 6, 2016
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)232.64 EUR
Upside (mean)+20.9%
Target Range208.00 EUR – 262.00 EUR
€208.00+20.9% to mean€262.00
# Analysts14
Ownership
Shares Out.97.28M
Float27.62M
Insiders71.50%
Institutions11.57%
Technical
SMA 50176.21 (+9.2%)
SMA 200182.31 (+5.6%)
Beta1.14
S&P 52W Chg18.16%
Avg Vol (30d)43.66K
Avg Vol (10d)67.99K
Technical Indicators
RSI (14)68.5
MACD3.1745
MACD Signal1.5268
MACD Hist.+1.6476
BB Upper192.00 EUR
BB Middle176.51 EUR
BB Lower161.02 EUR
BB Width17.56%
ATR (14)6.790 EUR
Vol Ratio (20d)1.92x